(Q36303992)

13 August 2017

1 reference

title

Clinical use of serum digoxin concentrations (English)

1 reference

Cardiology and cardiovascular medicine

13 August 2017

0 references

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

17 October 2022

author name string

R. P. Lewis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1626495

17 October 2022

language of work or name

English

0 references

publication date

1 June 1992

1 reference

13 August 2017

4 June 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1626495

full work available at URL

17 October 2022

https://api.elsevier.com/content/article/PII:0002914992912586?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

https://api.elsevier.com/content/article/PII:0002914992912586?httpAccept=text/plain

17 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

American Journal of Cardiology

17 October 2022

published in

1 reference

13 August 2017

69

1 reference

13 August 2017

18

1 reference

13 August 2017

97G-106G; discussion 106G-107G

1 reference

Determination of Therapeutic and Toxic Serum Digoxin Concentrations by Radioimmunoassay

13 August 2017

1

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Digitalis intoxication. A prospective clinical study with serum level correlations

17 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

The evolving pattern of digoxin intoxication: observations at a large urban hospital from 1980 to 1988.

17 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

The onset and magnitude of the contractile response to commonly used digitalis glycosides in normal subjects

17 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Clinical pharmacology of digoxin

17 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Acute myocardial uptake of digoxin in humans: correlation with hemodynamic and electrocardiographic effects

17 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Effect of Digitalis on Systolic Time Intervals in Heart Failure

17 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Pharmacokinetics of digoxin: Relationship between response intensity and predicted compartmental drug levels in man

17 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Pharmacokinetics of digoxin: comparison of a two- and a three-compartment model in man

17 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Extension of the serum digoxin concentration--response relationship to patient management

17 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Variation in Biologic Availability of Digoxin from Four Preparations

17 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Bioavailability and Related Heart Function Index of Digoxin Capsules and Tablets in Cardiac Patients

17 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Decreased bioavailability of digoxin due to antacids and kaolin-pectin

17 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Marked decline in serum digoxin concentrations during an episode of severe diarrhea

17 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Decreased bioavailability of digoxin due to hypocholesterolemic interventions

17 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Absorption of Digoxin in Patients with Malabsorption Syndromes

17 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Digoxin-inactivating bacteria: identification in human gut flora

17 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Geographic differences in digoxin inactivation, a metabolic activity of the human anaerobic gut flora

17 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Inactivation of Digoxin by the Gut Flora: Reversal by Antibiotic Therapy

17 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Influence of gastric acidity on the bioavailability of digoxin

17 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Digitalis pharmacokinetics and metabolism

17 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

The effect of everyday exercise on steady state digoxin concentrations

17 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Effect of physical exercise on the pharmacokinetics of digoxin during maintenance treatment

17 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Digoxin metabolism in obesity

17 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

The digoxin-amiodarone interaction.

17 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Interaction between digoxin and indomethacin or ibuprofen

17 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Influence of spironolactone and its metabolite canrenone on serum digoxin assays

17 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

The effect of quinidine and other oral antiarrhythmic drugs on serum digoxin. A prospective study

17 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Quinidine-digoxin interaction: Time course and pharmacokinetics

17 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

The influence of verapamil on serum digoxin concentration

17 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Amiodarone-digoxin interaction: clinical significance, time course of development, potential pharmacokinetic mechanisms and therapeutic implications

17 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Effects of coadministration of propafenone on the pharmacokinetics of digoxin in healthy volunteer subjects

17 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Digoxin-verapamil interaction: reduction of biliary but not renal digoxin clearance in humans

17 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Tissue digoxin concentrations and digoxin effect during the quinidine-digoxin interaction.

17 October 2022

41

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

A nomogram for digoxin therapy

17 October 2022

43

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Administration of tritiated digoxin with and without a loading dose. A metabolic study

17 October 2022

44

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Effect of endogenous digoxin-like substances on the interpretation of high concentrations of digoxin in children

17 October 2022

46

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Digoxin immunoassay with monoclonal and polyclonal antibodies using time-resolved fluorometry

17 October 2022

49

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Relationship between plasma concentration and dose of digoxin in patients with and without renal impairment

17 October 2022

50

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Improved computer-assisted digoxin therapy. A method using feedback of measured serum digoxin concentrations

17 October 2022

51

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Application of a computerized medical decision-making process to the problem of digoxin intoxication

17 October 2022

52

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

A knowledge-based information system for monitoring drug levels

17 October 2022

53

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Therapeutic drug monitoring: improved performance through educational intervention

17 October 2022

54

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Serum concentration monitoring of cardiac glycosides. How helpful is it for adjusting dosage regimens?

17 October 2022

55

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

The value of therapeutic drug monitoring to the practising physician--an hypothesis in need of testing

17 October 2022

56

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Clinical value of serum digoxin assays in outpatients: improvement by the standardization of blood sampling

17 October 2022

57

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Effects of Maintenance Digoxin Therapy on Systolic Time Intervals and Serum Digoxin Concentrations

17 October 2022

59

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Dose-response relationships and plasma concentrations of digitalis glycosides in man

17 October 2022

60

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Classical concentration-response relationship between serum digoxin level and contractility indices

17 October 2022

61

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Maintenance of the inotropic effect of digoxin on long-term treatment.

17 October 2022

62

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Is maintenance digoxin necessary in patients with sinus rhythm?

17 October 2022

65

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Reduction of digoxin toxicity associated with measurement of serum levels. A report from the Boston Collaborative Drug Surveillance Program

17 October 2022

66

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

Effect of Digoxin on Ejection Fraction in Elderly Patients with Congestive Heart Failure

17 October 2022

67

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91258-6

17 October 2022

Identifiers

1 reference

13 August 2017

1 reference